Common Contraindications Active or recent cancer (BPC-157 and TB-500 angiogenesis concern), Wilson's disease or other copper metabolism disorders (GHK-Cu component), pregnancy or breastfeeding (no safety data for any component), and competitive sport at WADA-tested levels (BPC-157 and TB-500 are listed under WADA category S0 Unapproved Substances) are commonly cited reasons not to research KLOW
The small human clock-gene study did not provide adequate safety reporting
For side effect details, see our GHK-Cu side effects guide
2) Applications: - Dry/sensitive skin moisturizers, barrier-repair emulsions
Deficiency is more common than many people realise particularly in those following plant-based diets, individuals with gastrointestinal conditions affecting absorption, and older adults
These treatments have gained popularity for their reported effects on weight management and well-being